Showing results (61-70 of 1,404) with videos related to
Sort By:
Pageof 141
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2011
Antiangiogenic agents should be integrated into the standard treatment for patients with ovarian cancerR A BurgerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2019
Going through Changes: Surface IgM Levels during CLL Therapy with IbrutinibJan A BurgerExpert Opinion on Medical Diagnostics|March 14, 2013
The times they are a-changin': prognostic markers in the new era of BCR-targeting therapies for CLLJan A BurgerJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Experience with bevacizumab in the management of epithelial ovarian cancerRobert A BurgerCurrent Hematologic Malignancy Reports|November 23, 2011
Inhibiting B-cell receptor signaling pathways in chronic lymphocytic leukemiaJan A BurgerAdvances in Experimental Medicine and Biology|September 10, 2013
The CLL cell microenvironmentJan A BurgerCurrent Opinion in Oncology|September 11, 2012
Targeting the microenvironment in chronic lymphocytic leukemia is changing the therapeutic landscapeJan A BurgerCancer Journal (Sudbury, Mass.)|August 16, 2021
Integrating New Therapies for Chronic Lymphocytic LeukemiaJan A BurgerOne Health (Amsterdam, Netherlands)|March 12, 2024
Integrating One Health into Systems SciencePamela A BurgerAnnales D'Endocrinologie|December 1, 1982
[Neuroendocrinology of puberty. Role of melatonin in man]P C Sizonenko, U Lang, M L AubertPageof 141